5.59 USD
↗ 0.21 (3.90%)AT CLOSE (11:59 AM EDT)
Insight Molecular Diagnostics Inc. Common Stock
IMDXNASDAQ • USD
5.59
↘ 0.01 (0.09%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
5.59
↘ 0.01 (0.09%)
Market: CLOSED
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $5.58. IMDX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (447.5%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 25, 2026.
Open?$5.47
High?$5.69
Low?$5.45
Prev. Close?$5.38
Volume?153.8K
Avg. Volume?332.1K
VWAP?$5.55
Rel. Volume?0.46x
Bid / Ask
Bid?$4.72 × 100
Ask?$6.39 × 100
Spread?$1.67
Midpoint?$5.56
Valuation & Ratios
Market Cap?173.7M
Shares Out?32.3M
Float?25.5M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-16.25
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
173.7M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.87Distress
Confidence?25%Very Low
Short InterestModerate
Short % of Float?4.50%Low
Short Interest?1.1M
Days to Cover?4.4
Free Float25.5M
Avg Daily Volume262.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.48Strong
Quick Ratio?2.45Strong
Cash Ratio?2.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-16.25CHEAP▾
S&P97
P/S?89.13HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?74.66HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?447.5%STRONG▾
Peers50
S&P97
ROA?-118.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27456000
Enterprise Value?$145.5M
Fundamentals ratios updated end of day